Skip to main content
NP

Neurana Pharmaceuticals

Neurana Pharmaceuticals is developing a novel pharmacological treatment for acute muscle spasms that targets specific neuromuscular pathways to provide rapid relief. This approach aims to reduce the frequency and severity of spasms, improving patient mobility and quality of life.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

  • Okay, I understand. I will analyze the provided "original description" and "website content" (when available), and then generate a new startup description that adheres to the specified structure, content, and writing guidelines. I will focus on clarity, accuracy, and the use of appropriate technical terminology, while avoiding hype and unnecessary details. I will also ensure that the response includes only the requested XML-formatted description.
This profile is AI-generated and may contain inaccuracies.